Navigation Links
New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
Date:10/24/2007

that AMBIEN CR is not only an effective treatment option to help patients with chronic insomnia fall and stay asleep, but is also associated with significant improvements in work performance. In that the performance improvements were correlated with the clinical improvements, this analysis demonstrated that AMBIEN CR-treated patients did better at work because their sleep improved."

About the Study

Treatments were administered from three to seven nights a week during a six-month period. Work outcomes were measured by the Work Limitation Questionnaire (WLQ), a self-administrated questionnaire measuring the degree to which health problems interfere with the ability to perform job roles. Patients were asked to rate their level of performance on 25 specific job demands by assigning scores ranging from 0 (limitations none of the time) to 100 (limitations all of the time). WLQ outcomes were assessed at baseline, week 4, 12, and end of treatment (week 24) or premature discontinuation. Two of the WLQ scales were included in the study: worker output and time management. Worker output assessed the ability to meet demands for quantity and quality of work while completing tasks in a timely manner. Time management assessed the ability to meet time demands and cope with scheduling pressures.

Study Results

In patients treated with AMBIEN CR, mean output scores improved by 14.1 points compared to 9.3 points for placebo. Mean time management scores improved by 17.8 points for AMBIEN CR-treated patients compared to 8.6 points for placebo. While both AMBIEN CR and placebo decreased work output and time management scores between baseline and week 12, the changes were significantly higher in AMBIEN CR compared to placebo. Performance improvements were clinically valid, as improvements in the WLQ scores for AMBIEN CR-treated patients were correlated with improvements in subjective scores from the same patients.

Safety analyses, conducted in patients who too
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
4. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Engineered Technologies (HDT), a leader in the development ... for the mechanical development of the Modular Prosthetic ... technology that will give patients improved, dexterous control ... sense of touch. ,, As part of ... Prosthetics 2009 (RP2009) project, the MPL overcomes the ...
(Date:12/16/2009)... Dec. 16 DATATRAK International, Inc. ... focused on global eClinical solutions for the ... of its version 9.0 eClinical Software. ... for product and service delivery and introduces ... Knowledge(TM) offering: the DATATRAK Learning Center(TM) and ...
(Date:12/16/2009)... 16 Scientists at,deCODE genetics, Inc. (Nasdaq: ... of a version of a common single-letter variant ... a major impact on susceptibility to type 2,diabetes ... not only large, but unusual:,if an individual inherits ... of,T2D by more than 30% compared to those ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 1Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 2Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 3Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 4New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 1New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 2New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 3New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 4New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 5Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 1Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 2Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 3Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 4
... Changes Affect Region with Higher Incidence of ... Hypertension in United ... innovator and leader of BioZ(R) impedance cardiography (ICG),technology, today announced ... (CMS) recently made changes to their,coverage policies that allowed expanded ...
... Cites Continuing Progress on Clinical and Preclinical Programs, ... (Amex: KAL; FWB: CA4), a developer of new ... diseases, is pleased to provide an,update covering its ... of 2007. "Callisto has made substantial progress ...
Other Medicine Technology:Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 2Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 3Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 4Callisto Reports on Second-Quarter 2007 Milestones 2Callisto Reports on Second-Quarter 2007 Milestones 3Callisto Reports on Second-Quarter 2007 Milestones 4
(Date:12/16/2009)... companies through annual marketing campaign , ... ... the 2010 Genetown™ Hotbed Campaign as its largest ... is sponsored by MassBio and showcases 37 Massachusetts ... places each entity’s brand on an electronic and printed ...
(Date:12/16/2009)... SAN FRANCISCO, Dec. 16 Shoppers like ... States, Mexico or Argentina. But grocers have found ... Origin Labeling (COOL) laws requiring them to provide ... specific website at easyCOOLnow.com for easily ... COOL laws include provisions that require retailers of ...
(Date:12/16/2009)... -- New research published online, December 10, ... and molecules present in pistachios, have anti-inflammatory ... of an inflammatory marker known as "Ifit-2" ... is a complex biological response to harmful ... it underlies functional changes associated with many ...
(Date:12/16/2009)... shrouded man found in a tomb on the edge of ... case of leprosy. Details of the research will be published ... The molecular investigation was undertaken by Prof. Mark Spigelman and ... for the Study of Infectious and Tropical Diseases at the ... Vernon of Lakehead University, Canada, Prof. Azriel Gorski of New ...
(Date:12/16/2009)... when the families of sick and dying hospitalized children ... them? How do pediatricians respond to such personal requests? ... spirituality help some patients and families cope with serious ... always the families and patients who raise the issue ... current issue of Southern Medical Journal , Brandeis ...
Breaking Medicine News(10 mins):Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Prayer on the hospital floor 2
... Faculty grants from the California Institute for Regenerative Medicine, ... investigation ultimately aimed at developing treatment strategies for such ... and amyotrophic lateral sclerosis. , The UCSF grants, which ... total $13.7 million and are intended to support the ...
... Receive Community Service, Gastroenterology and ... Diversity ... (NPs) to take a proactive approach to improving health care,in ... Nurse Practitioner Healthcare Foundation (NPHF) offers scholarships to,NPs who are ...
... India and BALTIMORE, Aug. 19 Lupin Ltd.,announced today ... marketing agreement for the AeroChamber Plus(R) line of products ... Lupin,Pharmaceuticals, Inc., USA, will use its 50 person sales ... is a Valved Holding Chamber (VHC) device that is,used ...
... Alliance Announce Strategic Partnership to ... Protecting Privacy, Through an innovative public/private partnership, ... privacy management and clinical trials ... Mass., Aug. 19 Private Access,Inc., and Genetic Alliance, ...
... VIENNA, Va., Aug. 19 Prematics, Inc. is ... to the company,s executive,management team as vice president ... regionally focused roll-outs of Prematics, clinical IT services,that ... the,physician practice., (Logo: http://www.newscom.com/cgi-bin/prnh/20060623/PREMATICSLOGO ), ...
... MD, August 18, 2008Young researchers presented innovative, early-stage ... a collaborative project of the AUA Foundation and ... August 7-9, 2008. The AUA Foundation hosted the ... the most cutting-edge research in sexual medicine. ...
Other Medicine News:Health News:UCSF faculty receive $13.7M from CIRM for stem cell research 2Health News:UCSF faculty receive $13.7M from CIRM for stem cell research 3Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 2Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 3Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 4Health News:Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians 2Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 2Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 3Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 4Health News:Prematics Names Dean M. Panovich Vice President, Deployment 2Health News:New research on sexual function 2
... The DataMate Laser Sheeted ... consists of laser-printable sheets ... wristband and laser labels ... The wristbands clear, fold-over ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... Wristbands and Tags print in mere ... transfer printers. Direct thermal printers use ... coating under the bands protective surface. ... transfer highly durable ink from a ...
... Perfect for use in settings where a ... infants and where an easy to apply but ... size can be selected to suit the child. ... used with a parents wristband to ensure proper ...
Medicine Products: